A pharmaceutical company involved in developing treatments, with a portfolio of FDA-approved drugs, but currently not active in the rare disease space or holding orphan drug designations.
0
Orphan Designations
9
FDA Approvals
Latest: ESCITALOPRAM (2025)
0
Active Trials
0
Rare Diseases
0
News (30d)
Quiet
Almatica Pharma LLC is a company with 0 orphan drug designations across 0 rare diseases, including 9 FDA-approved therapies.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
No pipeline data available yet.